Atrium Therapeutics, Inc. Common Stock (RNA) short volume · rev $22.6M
Atrium Therapeutics, Inc. Common Stock FINRA short-volume cache. Latest 2026-08-18.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-08-18 | 8,105 | 37,590 | 21.6% |
| 2026-08-17 | 26,871 | 63,339 | 42.4% |
| 2026-08-14 | 38,279 | 56,733 | 67.5% |
| 2026-08-13 | 10,289 | 36,893 | 27.9% |
| 2026-08-12 | 8,310 | 26,788 | 31.0% |
| 2026-08-11 | 9,334 | 28,296 | 33.0% |
| 2026-08-10 | 9,765 | 38,151 | 25.6% |
| 2026-08-07 | 15,044 | 36,932 | 40.7% |
| 2026-08-06 | 10,734 | 39,042 | 27.5% |
| 2026-08-05 | 17,875 | 65,948 | 27.1% |
FAQ
What is RNA P/E and revenue?
Atrium Therapeutics, Inc. Common Stock (RNA) rev $22.6M.
What is RNA short volume?
Atrium Therapeutics, Inc. Common Stock last cached short volume is 21.6% of total volume on 2026-08-18.
Not investment advice. Cached rows, not a live tape.